ACNE THERAPEUTICS MARKET ANALYSIS

Acne Therapeutics Market, By Treatment (Therapeutics, Retinoid, Antibiotics, Hormonal Agents, Combination Medications, Anti-inflammatory, and Other Agents) and By Route of Administration (Oral, Topical, and Others), And By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Mar 2025
Code : CMI5182
Pages :155
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Acne Therapeutics Market: Key Developments

In May 2023, Crown Therapeutics, a division of Crown Laboratories, announced that PanOxyl is expanding its award-winning portfolio with PM Balancing Repair Moisturizer and reformulating the existing AM Oil Control Moisturizer.

In July 2022, Sun Pharmaceutical Industries expanded the scope of its partnership with Cassiopea regarding a medication to treat acne. It has inked addendums to the licence and supply agreements for WINLEVI (clascoterone) cream 1 per cent, expanding the territory to include Japan, Australia, New Zealand, Brazil, Mexico and Russia.

In July 2022, STRATA Skin Sciences, Inc. announced the commercial launch of TheraClearX, a non-invasive, in-office acne treatment targeting the root causes of mild to moderate acne, including comedonal, pustular and inflammatory acne vulgaris.